Abstract
Rationale
Previously, we reported that chronic treatment with fluoxetine increased gene expression of 5-hydroxytryptamine receptor 2B (5-HT2BR), cytosolic phospholipase 2α (cPLA2α), glutamate receptor, ionotropic kainate 2 (GluK2) and adenosine deaminase acting on RNA 2 (ADAR2), in cultured astrocytes and astrocytes freshly isolated from transgenic mice tagged with an astrocyte-specific marker. In contrast, neurones isolated from transgenic mice tagged with a neurone-specific marker and exposed to fluoxetine showed an increase in gene expression of glutamate receptor, ionotropic kainate 4 (GluK4) and 5-hydroxytryptamine receptor 2C (5-HT2CR). In a mouse model of anhedonia, the downregulation of 5-HT2BR, cPLA2α, ADAR2 and GluK4 but not GluK2 and 5-HT2CR was detected.
Objective
To investigate the effects of chronic mild stress (CMS) and/or fluoxetine treatment on gene expression of 5-HT2BR, 5-HT2CR, cPLA2α, ADAR2, GluK2 and GluK4 specifically in astrocytes and neurones.
Methods
Transgenic mice tagged with either astrocyte- or neurone-specific markers were exposed to the CMS. Real-time PCR was applied to determine expression of messenger RNA (mRNA).
Results
We found that (i) mRNAs of the 5-HT2BR and cPLA2α in astrocytes and GluK4 in neurones were significantly reduced in mice that became anhedonic; the mRNA levels were restored by fluoxetine treatment; (ii) ADAR2 in astrocytes was decreased by the CMS but showed no response to fluoxetine in anhedonic animals; (iii) neither GluK2 expression in astrocytes nor 5-HT2CR expression in neurones were affected in anhedonic animals, although expression of 5-HT2CR mRNA was upregulated by fluoxetine.
Conclusions
Our results indicate that the effects of chronic treatment with fluoxetine are not only dependent on the cell type studied but also on the development of anhedonia. This suggests that fluoxetine may affect major depression (MD) patients and healthy people in a different manner.
Similar content being viewed by others
Abbreviations
- 5-HT2B 5-HT2C :
-
5-Hydroxytryptamine receptors 2B and 2C
- ADAR:
-
Adenosine deaminases acting on RNA
- APV:
-
2-Amino-5-phosphonovalerate
- BSA:
-
Bovine serum albumin
- CMS:
-
Chronic mild stress
- cPLA2α :
-
Cytosolic phospholipase 2α
- DNQX:
-
6,7-Dinitroquinoxaline-2,3-dione
- EGF:
-
Epidermal growth factor
- ERK:
-
Extracellular signal-regulated kinase
- FACS:
-
Fluorescence-activated cell sorting
- Fgfr3:
-
Fibroblast growth factor receptor 3
- GABA:
-
γ-Aminobutyric acid
- Gabra-1:
-
Gamma-aminobutyric acid receptor subunit α-1
- GFAP:
-
Glial fibrillary acidic protein
- GFP:
-
Green fluorescent protein promoter
- Glt-1:
-
Glutamate transporter 1
- GluK2 and GluK4:
-
Glutamate receptor, ionotropic kainate 2 and 4
- KCC2:
-
Potassium-chloride transporter member 5
- MEM:
-
Minimum essential medium
- Mag:
-
Myelin-associated glycoprotein
- Mbp:
-
Myelin basic protein
- MD:
-
Major depression
- Mog:
-
Myelin-oligodendrocyte glycoprotein
- mRNA:
-
Messenger ribonucleic acid
- PCR:
-
Polymerase chain reaction
- PBS:
-
Phosphate-buffered saline
- SSRI:
-
Serotonin-specific reuptake inhibitor
- PI:
-
Propidium iodide
- PIPES:
-
Piperazine-N,N’-bis(2-ethanesulfonic acid)
- Snap25:
-
Synaptosomal-associated protein 25
- TBP:
-
TATAA-box binding protein
- Thy1:
-
Thymocyte antigen 1
- YFP:
-
Yellow fluorescent protein
References
Altshuler LL, Abulseoud OA, Foland-Ross L, Bartzokis G, Chang S, Mintz J, Hellemann G, Vinters HV (2010) Amygdala astrocyte reduction in subjects with major depressive disorder but not bipolar disorder. Bipolar Disord 12:541–549
Barbon A, Popoli M, la Via L, Moraschi S, Vallini I, Tardito D, Tiraboschi E, Musazzi L, Giambelli R, Gennarelli M, Racagni G, Barlati S (2006) Regulation of editing and expression of glutamate α-amino-propionic-acid (AMPA)/kainate receptors by antidepressant drugs. Biol Psychiatry 59:713–720
Barbon A, Orlandi C, la Via L, Caracciolo L, Tardito D, Musazzi L, Mallei A, Gennarelli M, Racagni G, Popoli M, Barlati S (2011) Antidepressant treatments change 5-HT2C receptor mRNA expression in rat prefrontal/frontal cortex and hippocampus. Neuropsychobiology 63:160–168
Bass CE, Griffin G, Grier M, Mahadevan A, Razdan RK, Martin BR (2002) SR-141716A-induced stimulation of locomotor activity. A structure-activity relationship study. Pharmacol Biochem Behav 74:31–40
Beneyto M, Kristiansen LV, Oni-Orisan A, McCullumsmith RE, Meador-Woodruff JH (2007) Abnormal glutamate receptor expression in the medial temporal lobe in schizophrenia and mood disorders. Neuropsychopharmacology 32:1888–1902
Buchsbaum MS, Wu J, Siegel BV, Hackett E, Trenary M, Abel L, Reynolds C (1997) Effect of sertraline on regional metabolic rate in patients with affective disorder. Biol Psychiatry 41:15–22
Catches JS, Xu J, Contractor A (2012) Genetic ablation of the GluK4 kainate receptor subunit causes anxiolytic and antidepressant-like behavior in mice. Behav Brain Res 228:406–414
Chen CX, Cho DS, Wang Q, Lai F, Carter KC, Nishikura K (2000) A third member of the RNA-specific adenosine deaminase gene family, ADAR3, contains both single- and double-stranded RNA binding domains. RNA 6:755–767
Edgar N, Sibille E (2012) A putative functional role for oligodendrocytes in mood regulation. Transl Psychiatry 2:e109
Felder CC, Kanterman RY, Ma AL, Axelrod J (1990) Serotonin stimulates phospholipase A2 and the release of arachidonic acid in hippocampal neurons by a type 2 serotonin receptor that is independent of inositolphospholipid hydrolysis. Proc Natl Acad Sci U S A 87:2187–2191
Feng G, Mellor RH, Bernstein M, Keller-Peck C, Nguyen QT, Wallace M, Nerbonne JM, Lichtman JW, Sanes JR (2000) Imaging neuronal subsets in transgenic mice expressing multiple spectral variants of GFP. Neuron 28:41–51
Fu H, Li B, Hertz L, Peng L (2012) Contributions in astrocytes of SMIT1/2 and HMIT to myo-inositol uptake at different concentrations and pH. Neurochem Int 61:187–194
Han QQ, Yu J (2014) Inflammation: a mechanism of depression? Neurosci Bull 30:515–523
Hertz L (2011) Astrocytic energy metabolism and glutamate formation—relevance for 13C-NMR spectroscopy and importance of cytosolic/mitochondrial trafficking. Magn Reson Imaging 29:1319–1329
Hertz L (2013) The glutamate-glutamine (GABA) cycle: importance of late postnatal development and potential reciprocal interactions between biosynthesis and degradation. Front Endocrinol (Lausanne) 4:59
Hertz L, Song D, Li B, Du T, Xu J, Gu L, Chen Y, Peng L (2014) Signal transduction in astrocytes during chronic or acute treatment with drugs (SSRIs, antibipolar drugs, GABA-ergic drugs, and benzodiazepines) ameliorating mood disorders. J Signal Transduct 2014:593934
Iwamoto K, Bundo M, Kato T (2009) Serotonin receptor 2C and mental disorders: genetic, expression and RNA editing studies. RNA Biol 6:248–253
Jaggi AS, Bhatia N, Kumar N, Singh N, Anand P, Dhawan R (2011) A review on animal models for screening potential anti-stress agents. Neurol Sci 32:993–1005
Kimbrell TA, Ketter TA, George MS, Little JT, Benson BE, Willis MW, Herscovitch P, Post RM (2002) Regional cerebral glucose utilization in patients with a range of severities of unipolar depression. Biol Psychiatry 51:237–252
Li B, Zhang S, Zhang H, Nu W, Cai L, Hertz L, Peng L (2008) Fluoxetine-mediated 5-HT2B receptor stimulation in astrocytes causes EGF receptor transactivation and ERK phosphorylation. Psychopharmacology (Berlin) 201:443–458
Li B, Zhang S, Li M, Hertz L, Peng L (2009) Chronic treatment of astrocytes with therapeutically relevant fluoxetine concentrations enhances cPLA2 expression secondary to 5-HT2B-induced, transactivation-mediated ERK1/2 phosphorylation. Psychopharmacology (Berlin) 207:1–12
Li B, Zhang S, Zhang H, Hertz L, Peng L (2011) Fluoxetine affects GluK2 editing, glutamate-evoked Ca2+ influx and extracellular signal-regulated kinase phosphorylation in mouse astrocytes. J Psychiatry Neurosci 36:322–338
Li B, Dong L, Wang B, Cai L, Jiang N, Peng L (2012) Cell type-specific gene expression and editing responses to chronic fluoxetine treatment in the in vivo mouse brain and their relevance for stress-induced anhedonia. Neurochem Res 37:2480–2495
Little JT, Ketter TA, Kimbrell TA, Danielson A, Benson B, Willis MW, Post RM (1996) Venlafaxine or bupropion responders but not nonresponders show baseline prefrontal and paralimbic hypometabolism compared with controls. Psychopharmacol Bull 32:629–635
Lovatt D, Sonnewald U, Waagepetersen HS, Schousboe A, He W, Lin JH, Han X, Takano T, Wang S, Sim FJ, Goldman SA, Nedergaard M (2007) The transcriptome and metabolic gene signature of protoplasmic astrocytes in the adult murine cortex. J Neurosci 27:12255–12266
Mayberg HS, Brannan SK, Tekell JL, Silva JA, Mahurin RK, McGinnis S, Jerabek PA (2000) Regional metabolic effects of fluoxetine in major depression: serial changes and relationship to clinical response. Biol Psychiatry 48:830–843
Nave KA, Ehrenreich H (2014) Myelination and oligodendrocyte functions in psychiatric diseases. JAMA Psychiatry 71:582–584
Paddock S, Laje G, Charney D, Rush AJ, Wilson AF, Sorant AJ, Lipsky R, Wisniewski SR, Manji H, McMahon FJ (2007) Association of GRIK4 with outcome of antidepressant treatment in the STAR*D cohort. Am J Psychiatry 164:1181–1188
Pae CU, Yu HS, Lee KU, Kim JJ, Lee CU, Lee SJ, Jun TY, Lee C, Paik IH (2004) BanI polymorphism of the cytosolic phospholipase A2 gene may confer susceptibility to the development of schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry 28:739–741
Peng PL, Zhong X, Tu W, Soundarapandian MM, Molner P, Zhu D, Lau L, Liu S, Liu F, Lu Y (2006) ADAR2-dependent RNA editing of AMPA receptor subunit GluR2 determines vulnerability of neurons in forebrain ischemia. Neuron 49:719–733
Peng L, Li B, Du T, Wang F, Hertz L (2012) Does conventional anti-bipolar and antidepressant drug therapy reduce NMDA-mediated neuronal excitation by downregulating astrocytic GluK2 function? Pharmacol Biochem Behav 100:712–725
Perez LJ, Diaz de Arce H, Cilloni F, Salviato A, Marciano S, Perera CL, Salomoni A, Beato MS, Romero A, Capua I, Cattoli G (2012) An SYBR Green-based real-time RT-PCR assay for the detection of H5 hemagglutinin subtype avian influenza virus. Mol Cell Probes 26:137–145
Pfaffl MW (2001) A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 29:e45
Rajkowska G, Miguel-Hidalgo JJ (2007) Gliogenesis and glial pathology in depression. CNS Neurol Disord Drug Targets 6:219–233
Rao JS, Ertley RN, Lee HJ, Rapoport SI, Bazinet RP (2006) Chronic fluoxetine upregulates activity, protein and mRNA levels of cytosolic phospholipase A2 in rat frontal cortex. Pharmacogenomics J 6:413–420
Rasgon NL, Kenna HA, Geist C, Small G, Silverman D (2008) Cerebral metabolic patterns in untreated postmenopausal women with major depressive disorder. Psychiatry Res 164:77–80
Seki M, Nawa H, Morioka T, Fukuchi T, Oite T, Abe H, Takei N (2002) Establishment of a novel enzyme-linked immunosorbent assay for Thy-1; quantitative assessment of neuronal degeneration. Neurosci Lett 329:185–188
Shaltiel G, Maeng S, Malkesman O, Pearson B, Schloesser RJ, Tragon T, Rogawski M, Gasior M, Luckenbaugh D, Chen G, Manji HK (2008) Evidence for the involvement of the kainate receptor subunit GluR6 (GRIK2) in mediating behavioral displays related to behavioral symptoms of mania. Mol Psychiatry 13:858–872
Singh M, Zimmerman MB, Beltz TG, Johnson AK (2009) Affect-related behaviors in mice misexpressing the RNA editing enzyme ADAR2. Physiol Behav 97:446–454
Singh M, Singh MM, Na E, Agassandian K, Zimmerman MB, Johnson AK (2011) Altered ADAR 2 equilibrium and 5HT2C R editing in the prefrontal cortex of ADAR 2 transgenic mice. Genes Brain Behav 10:637–647
Stein EJ, da Silveira Filho NG, Machado DC, Hipolide DC, Barlow K, Nobrega JN (2009) Chronic mild stress induces widespread decreases in thyroid hormone α1 receptor mRNA levels in brain—reversal by imipramine. Psychoneuroendocrinology 34:281–286
Strekalova T, Couch Y, Kholod N, Boyks M, Malin D, Leprince P, Steinbusch HM (2011) Update in the methodology of the chronic stress paradigm: internal control matters. Behav Brain Funct 7:9
Su KP, Huang SY, Peng CY, Lai HC, Huang CL, Chen YC, Aitchison KJ, Pariante CM (2010) Phospholipase A2 and cyclooxygenase 2 genes influence the risk of interferon-alpha-induced depression by regulating polyunsaturated fatty acids levels. Biol Psychiatry 67:550–557
Verkhratsky A, Butt AM (2013) Glial physiology and pathophysiology. Wiley-Blackwell, Chichester
Verkhratsky A, Nedergaard M (2014) Astroglial cradle in the life of the synapse. Philosophical Transactions of the Royal Society Series B 369:20130595
Videbech P (2000) PET measurements of brain glucose metabolism and blood flow in major depressive disorder: a critical review. Acta Psychiatr Scand 101:11–20
Zeidan-Chulia F, Salmina AB, Malinovskaya NA, Noda M, Verkhratsky A, Moreira JC (2014) The glial perspective of autism spectrum disorders. Neurosci Biobehav Rev 38:160–172
Acknowledgments
This study was supported by grant nos. 31000479 to BL and 31171036 to LP from the National Natural Science Foundation of China. AV was supported in part by the grant (agreement from August 27 2013, No. 02.В.49.21.0003) between The Ministry of Education and Science of the Russian Federation and Lobachevsky State University of Nizhny Novgorod and by the grant of the Russian Scientific Foundation No. 14-15-00633.
Author information
Authors and Affiliations
Corresponding author
Additional information
Lu Dong and Baoman Li contributed equally to this work.
Rights and permissions
About this article
Cite this article
Dong, L., Li, B., Verkhratsky, A. et al. Cell type-specific in vivo expression of genes encoding signalling molecules in the brain in response to chronic mild stress and chronic treatment with fluoxetine. Psychopharmacology 232, 2827–2835 (2015). https://doi.org/10.1007/s00213-015-3921-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00213-015-3921-2